000 01097 a2200301 4500
005 20250513074849.0
264 0 _c19930720
008 199307s 0 0 eng d
022 _a0041-1345
040 _aNLM
_beng
_cNLM
100 1 _aKizilisik, T A
245 0 0 _aCytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis.
_h[electronic resource]
260 _bTransplantation proceedings
_cJun 1993
300 _a2282-3 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAcyclovir
_xtherapeutic use
650 0 4 _aCytomegalovirus Infections
_xphysiopathology
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLiver Transplantation
_ximmunology
650 0 4 _aPostoperative Complications
_xmicrobiology
650 0 4 _aTime Factors
700 1 _aPreiksaitis, J K
700 1 _aKneteman, N M
773 0 _tTransplantation proceedings
_gvol. 25
_gno. 3
_gp. 2282-3
999 _c8390011
_d8390011